Novo Nordisk has added Thermo Fisher as a second external drug product maker for weight-loss drug Wegovy, according to reports. Earlier this year, Danish drugmaker Novo Nordisk said it had bolstered supply of semaglutide – approved as a ‘popular’ weight- loss drug under the brand Wegovy – through the addition of an undisclosed second contract development and manufacturing organization (CDMO). But news outlet Reuters disclosed the third-party yesterday. Citing sources close to the matter, Reuters said Thermo Fisher is tasked…

The Infectious Diseases & Vaccines (ID&V) unit will be scrapped, affecting up to 625 jobs, but manufacturing operations at the Leiden site will continue, says J&J. Within its Janssen Pharmaceutical division, J&J is closing most of its infectious diseases and vaccine development unit at the Leiden site, located about 30km southwest of Amsterdam, The Netherlands. A spokesperson from the firm confirmed the exit is inline with restructuring plans highlighted in its second quarter results. However, Janssen said it remains committed…